Form 10-Q PhaseBio Pharmaceuticals For: Jun 30
http://archive.fast-edgar.com/20220812/ASZ3Q22CZ222E2Z2222U22ZSCNIPZV2S3242
Filed on: August 12, 2022
Form 24F-2NT Columbia Funds Series For: May 31
X0101
24F-2NT
LIVE
1352280
XXXXXXXX
false
N-1A
Columbia Funds Series Trust II
290 Congress Street
Boston
MA
X1
02210
COLUMBIA DIVIDEND OPPORTUNITY FUND
S000031365
... (continue reading...)
Form 8-K ALLIANCEBERNSTEIN HOLDIN For: Aug 12
0000825313false00008253132022-08-122022-08-12UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): August 12, 2022 (August 10, 2022)ALLIANCEBERNSTEIN HOLDING L.P. (Exact name of registrant as specified in its charter)Delaware001-0981813-3434400(State or other jurisdiction ofincorporation or organization)... (continue reading...)
Form 13F-NT Nomura Islamic Asset For: Jun 30
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
Form 497K J.P. Morgan Exchange-Tra
J.P. MORGAN EXCHANGE-TRADED FUNDS
JPMorgan U.S. Dividend ETF
JPMorgan U.S. Minimum Volatility ETF
(each, a “Fund”)
(each, a series of J.P. Morgan Exchange-Traded Fund Trust)
Supplement dated August 12, 2022
to the Summary Prospectuses, Prospectus and Statement of Additional Information
dated March 1, 2022, as supplemented
NOTICE OF LIQUIDATION OF THE JPMORGAN U.S. DIVIDEND ETF AND JPMORGAN U.S. MINIMUM VOLATILITY ETF. The Board of Trustees (the “Board”) of... (continue reading...)
More SEC Filings
View Older Stories-
Form MA-I/A Crowe LLP
-
Form 8-K PhaseBio Pharmaceuticals For: Aug 12
-
Form MA-I/A Government Financial
-
Form 497K J.P. Morgan Exchange-Tra
-
Form 424B3 CITIGROUP INC
-
Form 4 Cohen & Steers Closed-En For: Aug 10 Filed by: Palma Jeffrey
-
Form 13F-NT Nomura Asset Management For: Jun 30
-
Form 13F-HR WHITE MOUNTAINS INSURANC For: Jun 30
-
Form 10-Q Summit Healthcare Acquis For: Jun 30
-
Form 13F-HR NOMURA ASSET MANAGEMENT For: Jun 30
-
Form 13F-HR Strategic Financial Serv For: Jun 30
-
Form 8-K AGBA Acquisition Ltd For: Aug 09
-
Form 13F-HR IAT REINSURANCE CO LTD. For: Jun 30
-
Form 10-Q First Seacoast Bancorp For: Jun 30
-
Form 8-K GATX CORP For: Aug 09
-
Form 24F-2NT COLUMBIA FUNDS SERIES For: May 31
-
Form 10-Q HCW Biologics Inc. For: Jun 30
-
Form 497 J.P. Morgan Exchange-Tra
-
Form 424B5 Crinetics Pharmaceutical
-
Form 8-K BIO KEY INTERNATIONAL For: Aug 12
-
Form 8-K Texas Roadhouse, Inc. For: Aug 11
-
Form 13F-NT Nomura Asset Management For: Jun 30
-
Form 424B3 Haleon plc
-
Form 13F-NT Nomura Asset Management For: Jun 30
-
Form 13F-HR First Western Trust Bank For: Jun 30
-
Form S-8 POINT Biopharma Global
-
Form 13F-HR Amitell Capital Pte Ltd For: Jun 30
-
Form 13F-HR Giverny Capital Inc. For: Jun 30
-
Form 6-K CHINA LIFE INSURANCE CO For: Aug 12
-
Form C Social. 121 LLC
-
Form 10-Q POINT Biopharma Global For: Jun 30
-
Form 6-K ARGENX SE For: Aug 11
-
Form D Long Boat Key Fund I,
-
Form 13F-HR Railway Pension Investme For: Jun 30
-
Form D/A Global Asset Backed Oppo
-
Form 4 TerrAscend Corp. For: Aug 10 Filed by: J.W. Opportunities Master Fund, Ltd.
-
Form 497K FEDERATED HERMES INSURAN
-
Form 10-Q PepGen Inc. For: Jun 30
-
Form D/A Global Asset Backed Oppo
-
Form D/A Anabranch Fund, LP
-
Form SC 13G Xos, Inc. Filed by: YA II PN, Ltd.
-
Form 8-K VYNE Therapeutics Inc. For: Aug 12
-
Form 424B5 Terns Pharmaceuticals,
-
Form 8-K Checkpoint Therapeutics, For: Aug 12
-
Form 425 CarLotz, Inc. Filed by: CarLotz, Inc.
-
Form 8-K BOSTON OMAHA Corp For: Aug 12
-
Form FWP Terns Pharmaceuticals, Filed by: Terns Pharmaceuticals, Inc.
-
Form D/A Sparta Global Opportunit
-
Form 8-K CarLotz, Inc. For: Aug 09
-
Form 8-K Axcella Health Inc. For: Aug 12
